Transglutaminase may mediate certain physiological effects of endogenous amines and of amine-containing therapeutical agents.
Transglutaminase mediation of the effects of certain primary amines and alcohols may be important in receptor coupling to physiological responses. Many of the therapeutic and toxic side effects of drugs also may be related to their covalent linkage of glutamine residues of key regulatory proteins through the catalytic action of transglutaminase. This paper suggests that important therapeutic agents such as digoxin, tetracycline, adriamycin, and actinomycin D may have some effects related to transglutaminase action.
D000588:Amines / Q000502:physiology*; D000818:Animals; D002301:Cardiac Glycosides / Q000378:metabolism; D002364:Caseins / Q000378:metabolism; D003609:Dactinomycin / Q000378:metabolism; D004317:Doxorubicin / Q000378:metabolism; D005973:Glutamine / Q000378:metabolism; D006128:Growth; D007700:Kinetics; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D009955:Ornithine Decarboxylase / Q000378:metabolism; D011700:Putrescine / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D013449:Sulfonamides / Q000378:metabolism; D005723:gamma-Glutamyltransferase / Q000502:physiology*
D000588:Amines; D002301:Cardiac Glycosides; D002364:Caseins; D011943:Receptors, Adrenergic, beta; D013449:Sulfonamides; D005973:Glutamine; D003609:Dactinomycin; D004317:Doxorubicin; D005723:gamma-Glutamyltransferase; D011972:Receptor, Insulin; D009955:Ornithine Decarboxylase; D011700:Putrescine